Brevel Highlights Fermentation-Based Chlorella Ingredient for High-Performance Nutrition

According to a recent LinkedIn post from Brevel Ltd, the company is promoting Purallis, a new chlorella-based ingredient positioned as a high-protein, nutrient-dense powder for use in food and beverage formulations. The post describes Purallis as containing 50% protein, a full amino acid profile, multiple vitamins and minerals, and various bioactive compounds such as antioxidants and chlorophyll.

The company’s LinkedIn post highlights that Purallis is produced indoors in sterile bioreactors using Brevel’s patented “illuminated fermentation” technology, which is presented as a way to ensure consistent nutritional composition and avoid contamination and heavy metals associated with outdoor pond-grown algae. The product is also framed as “GLP-1 friendly,” targeting consumers seeking more nutrition from fewer calories, which may align with rising demand linked to weight-loss and metabolic-health trends.

As shared in the post, Brevel is positioning Purallis for applications in sports nutrition, healthy aging, and functional beverages, indicating an ambition to capture value in higher-margin, performance-focused segments of the plant-based ingredients market. For investors, this emphasis on differentiated production technology and premium functional use-cases could signal a strategy to move beyond commodity plant proteins and potentially improve pricing power and margins.

If Purallis gains traction with formulators, Brevel could benefit from recurring B2B ingredient sales and deeper integration into customers’ product pipelines, which may support more predictable revenue streams over time. However, commercial impact will depend on the company’s ability to scale bioreactor capacity competitively, demonstrate cost-effective manufacturing versus rival microalgae and plant-based proteins, and secure regulatory and customer adoption in key markets.